AstraZeneca
AZN
#45
Rank
NZ$506.42 B
Marketcap
NZ$326.67
Share price
-0.37%
Change (1 day)
23.63%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$9.08

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$9.14. In 2024 the company made an earnings per share (EPS) of NZ$7.75 an increase over its 2023 EPS that were of NZ$6.56.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$9.0817.1%
2024NZ$7.7518.23%
2023NZ$6.5681.13%
2022NZ$3.62631.03%
2021NZ$0.50-88.11%
2020NZ$4.17136.89%
2019NZ$1.76-39.41%
2018NZ$2.90-28.27%
2017NZ$4.05-14.37%
2016NZ$4.7324.11%
2015NZ$3.81127.55%
2014NZ$1.67-51.96%
2013NZ$3.48-58.95%
2012NZ$8.49-32.2%
2011NZ$12.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.02 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.57 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.40-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.31 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.53-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.77 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.48 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.07-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.43-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK